Livongo provides a data science and technology enabled platform for detection of diabetes.
Livongo is the consumer digital health company that empowers people with chronic conditions to live a better life. It has developed a completely new approach for diabetes management that combines the latest technology with coaching. By offering the right information, tools, and support, at the right time, we provide our members with real-time, personalized insights, and support to make diabetes management easier. Its approach is leading to better financial and clinical outcomes while also creating a better experience for people with diabetes and their care team of family, friends, and medical professionals. It was founded in 2008 and is headquartered in Mountain View, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 25, 2019 | IPO | $355M | — | — | — | Detail |
Apr 11, 2018 | Series E | $104.99M | 10 | General Catalyst Kinnevik | — | Detail |
Mar 16, 2017 | Series D | $52.50M | 14 | General Catalyst Kinnevik | — | Detail |
Apr 12, 2016 | Series C | $44.50M | 11 | — | — | Detail |
Apr 7, 2015 | Series B | $20M | 2 | Kleiner Perkins | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
General Catalyst | Yes | Series E |
Kinnevik | Yes | Series E |
7wire Ventures | — | Series E |
Echo Health Ventures | — | Series E |
Kleiner Perkins | — | Series E |
M12 - Microsoft's Venture Fund | — | Series E |
Merck Global Health Innovation Fund | — | Series E |
Sapphire Ventures | — | Series E |
Threshold | — | Series E |
Zaffre Investments | — | Series E |
Livongo has acquired 3 organizations. Their most recent acquisition was Diabeto on Sep 13, 2017. They acquired Diabeto for 0.